|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM270785787 |
003 |
DE-627 |
005 |
20250221115156.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2017 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2017.03.017
|2 doi
|
028 |
5 |
2 |
|a pubmed25n0902.xml
|
035 |
|
|
|a (DE-627)NLM270785787
|
035 |
|
|
|a (NLM)28390965
|
035 |
|
|
|a (PII)S1521-6616(17)30010-4
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Shen, Long
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Autoantibodies, detection methods and panels for diagnosis of Sjögren's syndrome
|
264 |
|
1 |
|c 2017
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 06.11.2017
|
500 |
|
|
|a Date Revised 31.03.2022
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2017 Elsevier Inc. All rights reserved.
|
520 |
|
|
|a The presence of autoantibodies is one of several hallmarks of Sjögren's Syndrome, the detection of serum autoantibodies has a central role in the diagnosis and classification of Sjögren's syndrome. In this review, we will discuss autoantibodies that are helpful in the diagnosis of Sjögren's syndrome. This includes the traditional autoantibodies for disease classification (ANA, Anti-Ro/SSA, Anti-La/SSB, RF), autoantibodies identified from mouse models (Anti-SP1, Anti- PSP, Anti-CA6, and anti-alpha fodrin) and autoantibodies associated with other autoimmune disease (ACA, AMA, and Anti-CCP). We will also review the methods for the detection of autoantibodies and associated challenges for clinical results reporting. The significance of using an autoantibody panel for the diagnosis of SS will be also be reviewed
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Review
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a Autoantibodies
|
650 |
|
4 |
|a Detection methods
|
650 |
|
4 |
|a Sjögren's syndrome
|
650 |
|
7 |
|a Antibodies, Antinuclear
|2 NLM
|
650 |
|
7 |
|a Autoantibodies
|2 NLM
|
650 |
|
7 |
|a BPIFA2 protein, human
|2 NLM
|
650 |
|
7 |
|a Carrier Proteins
|2 NLM
|
650 |
|
7 |
|a Immunoglobulins
|2 NLM
|
650 |
|
7 |
|a Microfilament Proteins
|2 NLM
|
650 |
|
7 |
|a Peptides, Cyclic
|2 NLM
|
650 |
|
7 |
|a SP1 antigen
|2 NLM
|
650 |
|
7 |
|a SS-A antibodies
|2 NLM
|
650 |
|
7 |
|a SS-B antibodies
|2 NLM
|
650 |
|
7 |
|a Salivary Proteins and Peptides
|2 NLM
|
650 |
|
7 |
|a cyclic citrullinated peptide
|2 NLM
|
650 |
|
7 |
|a fodrin
|2 NLM
|
650 |
|
7 |
|a Rheumatoid Factor
|2 NLM
|
650 |
|
7 |
|a 9009-79-4
|2 NLM
|
650 |
|
7 |
|a Carbonic Anhydrases
|2 NLM
|
650 |
|
7 |
|a EC 4.2.1.1
|2 NLM
|
650 |
|
7 |
|a carbonic anhydrase VI
|2 NLM
|
650 |
|
7 |
|a EC 4.2.1.1
|2 NLM
|
700 |
1 |
|
|a Suresh, Lakshmanan
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 182(2017) vom: 01. Sept., Seite 24-29
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:182
|g year:2017
|g day:01
|g month:09
|g pages:24-29
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2017.03.017
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 182
|j 2017
|b 01
|c 09
|h 24-29
|